Tag: home haemodialysis
Quanta dialysis system receives US FDA clearance for home haemodialysis
Quanta Dialysis Technologies has confirmed the US Food and Drug Administration (FDA) has given 510(k) clearance for the use of its Quanta dialysis system...
Renal Interventions’ top 10 stories of April 2024
April was a month of world-firsts, new collaborations, and useful data, with a team from Massachusetts General Hospital (Boston, USA) performing the world’s first...
TELEGRAFT: The revolutionary artificial and sustainable graft for haemodialysis and bypass...
Jes S Lindholt, Thomas Emil Andersen and Martin Alm write together about TELEGRAFT, a prospective future graft solution that is being developed for the...
ASDIN programme chair highlights the dos and don’ts of vascular access,...
Dalia Dawoud (Nephrology Associates Medical Group, Azura Vascular Care, Riverside, USA)—the programme chair of the most recent American Society of Diagnostic and Interventional Nephrology...
Outset Medical and US Renal Care announce collaboration aimed to grow...
Outset Medical and US Renal Care have announced via press release a multi-year agreement to help accelerate home haemodialysis in the USA.
According to their announcement, studies...
Renal Interventions’ top 10 stories of February 2024
February was a month of trials beginning enrolment, novel technologies, and treatment protocols, with Gianmarco Falcone emphasising the need for a full protocol and...
Blood on the dialysis floor: An unforgettable night from 25 years...
It’s possible to expand the action radius of a passion for kitesurfing, despite being on long-term dialysis. Pascal Kopperschmidt (Hamburg, Germany) gave attendees at...
Outset Medical presents research on home haemodialysis in underserved populations
Outset Medical, the medical technology company responsible for the Tablo haemodialysis system, has presented five new abstracts that promise insights on the clinical and...
EVA 2022: The “way ahead” is increased flexibility offered by home...
At this year’s EndoVascular Access meeting (EVA; 24–25 June, Patras, Greece), Michael Aragon—nephrologist and chief medical officer of Outset Medical—outlined existing benefits and barriers to...
Quanta Dialysis Technologies wins top UK engineering innovation award
Quanta Dialysis Technologies has received the 2022 MacRobert Award in recognition of its efforts to develop the SC+ system—a portable, easy-to-use, high-performance dialysis machine...
B. Braun Avitum becomes exclusive UK distributor of dedicated home dialysis...
B. Braun Avitum has become the exclusive UK distributor for Physidia, a France-based manufacturer of a dedicated home dialysis machine, in a move that...
Outset Medical announces shipment hold on new Tablo haemodialysis systems for...
Outset Medical today announced it has implemented a shipment hold on the distribution of its Tablo haemodialysis system for home use pending the US...
Outset presents multiple data sets on home dialysis modalities at NKF...
Outset Medical has announced the release of three new data sets related to home dialysis—each of which are being presented during the ongoing National...
Dialyze Direct acquires Renew Dialysis from Saber Healthcare
Home haemodialysis provider Dialyze Direct has announced the acquisition of Renew Dialysis, a regional provider of on-site dialysis services in skilled nursing facilities (SNFs),...
Improved understanding of current dialysis modalities may hold greater value than...
There are several different types of dialysis treatment available to kidney disease patients—with the three major players, in-centre haemodialysis (ICHD), home haemodialysis (HHD) and...
Fresenius unveils intelligent home dialysis solutions at China International Import Expo
Fresenius Medical Care recently presented its advances in home dialysis solutions at the China International Import Expo (CIIE) in Shanghai, China. The company showcased...
Outset Medical gains landmark CMS approval for Tablo home haemodialysis system
Outset Medical has announced that its Tablo haemodialysis system has received the first ever approval from the Centers for Medicare & Medicaid Services (CMS) for...
Significant mortality increase seen after home haemodialysis failure compared to continued...
Failure of home haemodialysis (HHD) treatment, defined as a return to in-centre haemodialysis (ICHD), has been associated with a “significant increase” in mortality when...